On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

Earth Science Tech, Inc. (ETST) Plans to Battle Opioid Addiction with Human Clinical Trials in 2019

  • Centers for Disease Control and Prevention, in March 2018, estimated ‘economic burden’ of opioid misuse at $78.5 billion annually
  • ETST plans to complete white paper, begin human clinical trials by 2019; company intends to investigate drugs that combine mineral element and cannabinoid industrial hemp oil
  • Goal for biotech company is to fight opioid addiction with over-the-counter (OTC) treatment drug and a cannabinoid companion generic drug

Earth Science Tech, Inc. (OTC: ETST) is planning to fight opioid addiction in the near future by completing its white paper and beginning human clinical trials in 2019. The epidemic is projected to claim nearly 500,000 American lives by 2027, according to a study by STAT (http://cnw.fm/b0tPe).

The ETST white paper and planned human clinical studies deal with the measure of the efficacy of combination drugs against opioid dependency. The company will investigate the synergies between mineral elements and full spectrum cannabinoid industrial hemp with the goal of developing OTC and generic drugs that treat opioid addiction.

ETST is a biotech company focused on the cannabinoid, pharmaceutical and nutraceutical markets. In addition to drug research, it also performs R&D testing for medical devices. The company holds several subsidiaries, including Earth Science Pharmaceutical, Inc.; Cannabis Therapeutics, Inc.; KannaBidioiD, Inc.; and Canna Inno Laboratories, Inc., based in Montreal, Canada.

The company’s proposed OTC drug would be intended to reduce the cravings of opioid addicts. The other would be a generic designed to reduce the danger of side effects and make the first drug more effective, according to ETST. The purpose of the human trial is to develop a methodology that prevents fatal overdoses and relieves the side effects of withdrawal.

The Centers for Disease Control and Prevention (CDC), in a March 2018 revised report, estimated the ‘economic burden’ of opioid misuse at $78.5 billion annually in the U.S., including in that figure health care, addiction treatment and the involvement of the justice system. The National Institute on Drug Abuse terms it a national health crisis (http://cnw.fm/47HXc).

For more information, visit the company’s website at www.EarthScienceTech.com

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Archives

Select A Month

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722